Concise Analysis of the United States Regenerative Medicine Market - Forecasts to 2016

DUBLIN, Mar. 12, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/lkv8bk/regenerative) has announced the addition of the "Concise Analysis of the United States Regenerative Medicine Market - Forecasts to 2016" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

There is a high demand for synthetic organ transplants in the market. Regenerative medicine helps in the development of artificial organs. The introduction of artificial organs for implantation is expected to encourage many vendors and research organizations to develop advanced stem cell products, therapies, and regenerative products. It will also help reduce the long organ waiting list. For instance, custom-made windpipe can be made using regenerative products within a week. The first ever implant of a synthetic trachea took place in June 2011.

The synthetic trachea was made from minuscule plastic fibers and was covered in stem cells taken from a human bone marrow. Surgeons successfully implanted this synthetic trachea into a 36-year-old patient with late-stage tracheal cancer at Karolinska University Hospital in Stockholm.

Thus, the use of synthetic organs in transplant surgeries is expected to have a positive impact on the growth of the market. According to the report, one of the main drivers of this market is the increasing prevalence of degenerative diseases. Regenerative products have helped in addressing the unmet needs of various disease areas. Another major driver of the market is the significant advances seen in R&D.

Key Topics Covered:

1. Executive Summary

2. List of Abbreviations

3. Introduction

4. Market Research Methodology

5. Scope of the Report

6. Market Landscape

7. Vendor Landscape

8. Buying Criteria

9. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Key Vendor Analysis

15. Other Reports in this Series

Companies Mentioned:

Advanced Cell Technology Inc. Arteriocyte Inc. Athersys Inc. Baxter International Inc. CryoLife Cytori Therapeutics Inc. Genzyme Corp. Geron Corp. InVivo Therapeutics Inc. Integra Life Sciences Holdings Corp. Kensey Nash Corp. Kinetic Concepts Inc. Medtronic Inc. NeoStem Inc. Osiris Therapeutics Inc. Osteotech Inc. RTI Biologics Inc. Stryker Corp. Zimmer Holdings Inc.
For more information visit http://www.researchandmarkets.com/research/lkv8bk/regenerative

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets

RELATED LINKS
http://www.researchandmarkets.com/